Kuczera M, Hilgers K F, Lisson C, Ganten D, Hilgenfeldt U, Ritz E, Mann J F
Department of Medicine, University of Heidelberg, Federal Republic of Germany.
J Hypertens. 1991 Jan;9(1):41-8.
To examine and characterize the vascular renin--angiotensin system in low-renin models of renal hypertension with and without the presence of overt renal insufficiency, we studied the formation and metabolism of angiotensin in isolated perfused rat hindquarter preparations. Rats with 5/6 nephrectomy (5/6NX) and rats with one-kidney, one clip (1K1C) hypertension were compared to sham operated (sham) animals. Angiotensin peptides in plasma or perfusate were characterized by high-performance liquid chromatography and radioimmunoassay (RIA). Plasma angiotensin II was lower, and blood pressure was higher in both experimental groups, compared to sham animals. Plasma angiotensinogen, measured by both direct and indirect RIA, was increased in both experimental groups. The spontaneous release of angiotensin I and angiotensin II from perfused hindquarters did not differ between the groups. Angiotensin I conversion was not different in 5/6NX or 1K1C groups compared with controls. Furthermore, angiotensin conversion was completely inhibited by captopril (1 mumol/l) in all groups. Renin-induced angiotensin release was significantly increased in 5/6NX as compared with sham rats, whereas there was no difference in renin-induced angiotensin release between 1K1C and sham animals. Angiotensin II degradation was significantly attenuated in 5/6NX rats when compared with sham rats (27.6% versus 53.9%, respectively, P less than 0.05) but was unaltered in 1K1C rats. Thus, in chronic uremic hypertension, renin-induced angiotensin formation was increased in the face of decreased angiotensin II degradation. These data suggest that vascular angiotensin may contribute to the elevated blood pressure observed in chronic renal failure. In 1K1C rats, vascular angiotensin formation and metabolism was unchanged despite suppressed plasma angiotensin II.
为了研究伴有或不伴有明显肾功能不全的低肾素型肾性高血压模型中的血管肾素 - 血管紧张素系统并对其进行特征描述,我们在离体灌注大鼠后肢标本中研究了血管紧张素的生成和代谢。将行5/6肾切除术(5/6NX)的大鼠和单肾单夹(1K1C)高血压大鼠与假手术(假手术组)动物进行比较。通过高效液相色谱法和放射免疫测定法(RIA)对血浆或灌注液中的血管紧张素肽进行特征描述。与假手术组动物相比,两个实验组的血浆血管紧张素II水平较低,血压较高。通过直接和间接RIA测定的血浆血管紧张素原在两个实验组中均升高。灌注后肢中血管紧张素I和血管紧张素II的自发释放组间无差异。5/6NX组或1K1C组与对照组相比,血管紧张素I转换无差异。此外,所有组中卡托普利(1μmol/L)均完全抑制血管紧张素转换。与假手术大鼠相比,5/6NX组中肾素诱导的血管紧张素释放显著增加,而1K1C组与假手术动物之间肾素诱导的血管紧张素释放无差异。与假手术大鼠相比,5/6NX大鼠中血管紧张素II降解显著减弱(分别为27.6%对53.9%,P<0.05),但1K1C大鼠中未改变。因此,在慢性尿毒症性高血压中,尽管血管紧张素II降解减少,但肾素诱导的血管紧张素生成增加。这些数据表明,血管紧张素可能导致慢性肾衰竭中观察到的血压升高。在1K1C大鼠中,尽管血浆血管紧张素II受到抑制,但血管紧张素的生成和代谢未改变。